Home›People›Jonathan Cohen
JC

Jonathan Cohen

Chief Executive Officer and director at 20/20 GeneSystems.

ExecutiveDirectorPublic company
Updated Oct 29, 2026·Latest SEC filing Mar 4, 2026·Suggest an edit

About Jonathan Cohen

Jonathan Cohen is a chief executive officer and director at 20/20 GeneSystems.

Jonathan Cohen reports to the SEC as a director, officer or major shareholder of 1 public company: 20/20 Biolabs (AIDX).

Jonathan Cohen first appears on SEC filings in 2015.

Experience

This experience comes from SEC filings. The years are when the filings name Jonathan Cohen in the role, so the role may have started earlier or lasted longer.

20/20 GeneSystems, Inc.
Chief Executive Officer and director
2015 – 2026 · Public company (AIDX)

Key Colleagues at Startups

The people Jonathan Cohen works with at each company, as listed on that company's latest Form D.

20/20 GeneSystems, Inc. · Form D, Feb 26, 2025
PR
JC
John Compton
Director
JR
John Rollins
Director
WL
Wei Lu
Director
RC
AS
Anne Shiflett
Executive officer
JZ
Jiminy Zhou
Executive officer
MR
Michael Ross
Director

Sources

  1. SEC20/20 GeneSystems, Inc. Form D, filed Feb 26, 2025
  2. SECForms 3, 4 and 5 filed by Jonathan Cohen (SEC filer 2111543)